Nasdaq · Health Care · Drug Manufacturers - General
AMGN
Amgen Inc.
Discovers and manufactures biotech drugs for cancer, inflammation and bone disease.
$415.21-0.63%
Close · 2026-08-14$300$350$400
NovFebMayAug
$264.02
$421.7952-week range, last close at 96% of the range
- 1W
- +1.04%
- 1M
- +15.88%
- 3M
- +27.24%
- 6M
- +13.31%
- YTD
- +28.70%
- 1Y
- +47.33%
- Avg vol 20d
- 2.7M
- RVOL
- 0.63
- HOLD band
Fundamentalsas of 2026-08-14
- Mkt cap
- $224.63B
- P/E
- 25.8
- Fwd P/E
- 17.1
- EPS
- $16.09
- Div yield
- 2.43%
- Beta
- 0.41
- Employees
- 31.5K
- Next earnings
- 2026-11-03
Rating & verdict historyoldest → newest
100.0% correct+1.52% avg moveBUY 0/0 · HOLD 1/1 · SELL 0/0
| Date | Call | Outcome | Return | Takeaway |
|---|---|---|---|---|
| 2026-08-14 | Subscribers | — | — | Subscribe to read |
| 2026-08-13 | Subscribers | — | — | Subscribe to read |
| 2026-08-12 | Subscribers | — | — | Subscribe to read |
| 2026-08-11 | Subscribers | — | — | Subscribe to read |
| 2026-08-10 | Subscribers |